Literature DB >> 23723183

Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.

Nico Langer1, Rainer Lindigkeit, Hans-Martin Schiebel, Ludger Ernst, Till Beuerle.   

Abstract

Synthetic compounds mimicking cannabis-like effects are a recent trend. Currently, these so-called synthetic cannabinoids are the largest and fastest growing class of newly appearing designer drugs. Many national authorities are continuously adapting their regulations to keep pace with the permanently changing variety of compounds. We have analyzed eight herbal smoking blends containing synthetic cannabinoids. Altogether, nine compounds could be identified, namely AM-2201, AM-2201-pMe (MAM-2201), AM-1220, AM-1220-azepane, UR-144, XLR-11, JWH-122-pentenyl, AM-2232, and STS-135. Newly appearing compounds were isolated by column chromatography and their structures elucidated by 1D- and 2D-nuclear magnetic resonance (NMR) experiments. In addition, the compounds were investigated by electron ionization-mass spectrometry (EI-MS) and electrospray ionization-tandem mass spectrometry (ESI-MS/MS) to complete the physicochemical dataset. Based on the purified compounds a universal gas chromatography-mass spectrometry (GC-MS) method was developed for the identification and quantification of these compounds in commercial smoking blends. By applying this method, up to five different compounds could be found in such products showing total concentrations from 72 to 303 mg/g smoking blend while individual compounds ranged from 0.4 to 303 mg/g. (1)H NMR spectra of the chiral compounds AM-1220 and its azepane-isomer recorded in the presence of 1 equivalent of (R)-(+)-α-methoxy-α-trifluoromethylphenylacetic acid (MTPA, Mosher's acid) showed them to be racemic mixtures.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NMR; Spice; mass spectrometry; synthetic cannabinoids

Mesh:

Substances:

Year:  2013        PMID: 23723183     DOI: 10.1002/dta.1499

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  12 in total

1.  Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Authors:  Julie A Marusich; Jenny L Wiley; Timothy W Lefever; Purvi R Patel; Brian F Thomas
Journal:  Neuropharmacology       Date:  2017-11-04       Impact factor: 5.250

2.  Isolation of Natural DNA Aptamers for Challenging Small-Molecule Targets, Cannabinoids.

Authors:  Haixiang Yu; Yingping Luo; Obtin Alkhamis; Juan Canoura; Boyang Yu; Yi Xiao
Journal:  Anal Chem       Date:  2021-02-02       Impact factor: 6.986

3.  Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.

Authors:  Vera L Alves; João L Gonçalves; Joselin Aguiar; Maria J Caldeira; Helena M Teixeira; José S Câmara
Journal:  Anal Bioanal Chem       Date:  2021-02-11       Impact factor: 4.142

4.  Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; Shanlin Fu
Journal:  AAPS J       Date:  2018-03-08       Impact factor: 4.009

5.  High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.

Authors:  Adarsh S Gandhi; Ariane Wohlfarth; Mingshe Zhu; Shaokun Pang; Marisol Castaneto; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-05-14       Impact factor: 3.345

6.  Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.

Authors:  Claude Guillou; Fabiano Reniero; Joana Lobo Vicente; Margaret Holland; Kamil Kolar; Hubert Chassaigne; Salvatore Tirendi; Herve Schepers
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

7.  AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

Authors:  Ju-Hyun Kim; Soon-Sang Kwon; Tae Yeon Kong; Jae Chul Cheong; Hee Seung Kim; Moon Kyo In; Hye Suk Lee
Journal:  Molecules       Date:  2017-03-10       Impact factor: 4.411

8.  CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist.

Authors:  Richard C Kevin; Lyndsey Anderson; Iain S McGregor; Rochelle Boyd; Jamie J Manning; Michelle Glass; Mark Connor; Samuel D Banister
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

Review 9.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20

10.  In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; Shanlin Fu
Journal:  Forensic Toxicol       Date:  2018-05-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.